Castle Biosciences Inc (CSTL)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 38.64M | 42.04M | 50.14M | 61.49M | 66.12M | 72.97M | 87M | 85.78M |
Operating Income | -22.83M | -31.52M | -21.16M | -9.64M | -5.66M | -5.47M | 5.01M | 5.08M |
Pre Tax Income | -20.56M | -29.19M | -18.76M | -6.87M | -2.54M | -2.49M | 7.89M | 8.28M |
Net Income | -20.62M | -29.2M | -18.78M | -6.91M | -2.58M | -2.53M | 8.92M | 2.27M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -22.83M | -31.52M | -21.16M | -9.64M | -5.66M | -5.47M | 5.01M | 5.08M |
EBITDA | -19.99M | -28.63M | -19.58M | -5M | -2.43M | -2.13M | 8.36M | 8.62M |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 13.75M | 22.79M | 51.87M | 64.53M | 94.09M | 155.33M | 219.79M |
Operating Income | -10.9M | -3.84M | 7.33M | -6.54M | -40.08M | -72.86M | -67.98M |
Pre Tax Income | -12.36M | -6.36M | 5.35M | -10.2M | -40.01M | -68.9M | -57.37M |
Net Income | -15.31M | -10.16M | 2.99M | -10.28M | -31.29M | -67.14M | -57.47M |
Preferred Dividends | -2.94M | -3.8M | -2.16M | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -6.621 | -4.351 | 0.175 | -0.414 | -1.233 | -2.646 | -2.135 |
EBIT | -10.74M | -4.11M | 9.85M | -7.94M | -40.08M | -72.86M | -67.98M |
EBITDA | -10.59M | -3.51M | 7.69M | -6.07M | -36.67M | -62.31M | -55.65M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.